2Ray K,Bala M,Kumsri S1,et al.Antinmicrobial resistance stance of neisseria gonorrhoeae in selected world health organization southeast asia re2gion countries:an overview[J].Sex Transm Dis,2005,32(3):178 - 184
8Brannigan,Tirodimos IA,Zhang QY,et al.Insertion of extra amino and is the main cause of the low affinity of penicillinbinding protein in penicillinresisitant strains of n eisseriagonrrhoeae[J].MolMicrobiol,1990,4(6):913 - 919
9Hagman KE,Lucas CE,Balthazar JT,et al The MtrD protein of Neisseria gonorrhoeae in a memeber of the resistance/nodulatinn/division protein family constituting part of and efflucx system[J].Microbiology,1997,143:2117 - 2125
8Zarantonelli L, Borthagaray G, Lee E H et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. J Antimicrob Agents Chemother,1999,43:2468.
9Cousin S J, Roberts M C, Whittington W L. Insertion of a thymine (+T) in the 13 base pair inverted repeat of the Neisseria gonorrhoeae mtr promoter region and antibiotic susceptibility.Int J Antimicrob Agents, 2004,23:418.
10Veal W L, Nicholas R A, Shafer W M. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae.J Bacteriol, 2002, 184:5619.
3Hack JB,Hecht C. Emergency physicians'patterns of treatment for presumed gonorrhea and chlamydia in women:one center's practice[J].{H}Emergency Medicine,2009,(03):257-263.
4Campos-Outcalt D. CDC update on gonorrhea.expand treatment to limit resistance[J].{H}FAMILY PRACTICE,2011,(12):736-740.
5Dowell D,Tian LH,Stover JA. Changes in Fluoroquinolone Use for Gonorrhea Following Publication of Revised Treatment Guidelines[J].{H}AMERICAN JOURNAL OF PUBLIC HEALTH,2012,(01):148-155.
